Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity

por Buryova, Halka, Chalupsky, Karel, Zbodakova, Olga, Kanchev, Ivan, Jirouskova, Marketa, Gregor, Martin, Sedlacek, Radislav
Publicado 2013

ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis

por Zbodakova, Olga, Chalupsky, Karel, Sarnova, Lenka, Kasparek, Petr, Jirouskova, Marketa, Gregor, Martin, Sedlacek, Radislav
Publicado 2021

Hepatoprotective Effect of MMP-19 Deficiency in a Mouse Model of Chronic Liver Fibrosis

por Jirouskova, Marketa, Zbodakova, Olga, Gregor, Martin, Chalupsky, Karel, Sarnova, Lenka, Hajduch, Marian, Ehrmann, Jiri, Jirkovska, Marie, Sedlacek, Radislav
Publicado 2012

Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

por Gerckens, Michael, Schorpp, Kenji, Pelizza, Francesco, Wögrath, Melanie, Reichau, Kora, Ma, Huilong, Dworsky, Armando-Marco, Sengupta, Arunima, Stoleriu, Mircea Gabriel, Heinzelmann, Katharina, Merl-Pham, Juliane, Irmler, Martin, Alsafadi, Hani N., Trenkenschuh, Eduard, Sarnova, Lenka, Jirouskova, Marketa, Frieß, Wolfgang, Hauck, Stefanie M., Beckers, Johannes, Kneidinger, Nikolaus, Behr, Jürgen, Hilgendorff, Anne, Hadian, Kamyar, Lindner, Michael, Königshoff, Melanie, Eickelberg, Oliver, Gregor, Martin, Plettenburg, Oliver, Yildirim, Ali Önder, Burgstaller, Gerald
Publicado 2021